Multidrug Resistance Is Common in Escherichia coli Associated with Ileal Crohnʼs Disease (Q22252899)

2

Ellen

Scherl

1 reference

7 February 2023

Rhonda Yantiss

4

Rhonda

Yantiss

1 reference

7 February 2023

Craig Altier

5

Craig

Altier

1 reference

7 February 2023

Patrick L. McDonough

6

Patrick L

McDonough

1 reference

7 February 2023

Zhi-Dong Jiang

7

Zhi-Dong

Jiang

1 reference

7 February 2023

Philippe Garneau

9

Philippe

Garneau

1 reference

7 February 2023

Mark Rishniw

11

Mark

Rishniw

1 reference

7 February 2023

Kenneth W. Simpson

12

Kenneth W

Inflammatory Bowel Diseases

Simpson

1 reference

7 February 2023

language of work or name

English

0 references

publication date

January 2013

0 references

published in

0 references

volume

19

0 references

issue

1

0 references

page(s)

141-150

0 references

cites work

Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities

1 reference

Mechanisms of Disease: pathogenesis of Crohn's disease and ulcerative colitis

21 January 2018

1 reference

Pathogenic agents in inflammatory bowel diseases

21 January 2018

1 reference

Mycobacteria and Crohn's disease: the endless story

21 January 2018

1 reference

Culture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn's disease involving the ileum

21 January 2018

1 reference

Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases

21 January 2018

1 reference

Adherent-invasive Escherichia coli: a putative new E. coli pathotype associated with Crohn's disease

21 January 2018

1 reference

Invasive Escherichia coli are a feature of Crohn's disease

21 January 2018

1 reference

Molecular diversity of Escherichia coli in the human gut: new ecological evidence supporting the role of adherent-invasive E. coli (AIEC) in Crohn's disease

21 January 2018

1 reference

CEACAM6 acts as a receptor for adherent-invasive E. coli, supporting ileal mucosa colonization in Crohn disease

21 January 2018

1 reference

High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn’s disease

21 January 2018

1 reference

Abnormally expressed ER stress response chaperone Gp96 in CD favours adherent-invasive Escherichia coli invasion

21 January 2018

1 reference

Crohn's disease-associated adherent-invasive E. coli are selectively favoured by impaired autophagy to replicate intracellularly

21 January 2018

1 reference

Adherent and invasive Escherichia coli is associated with granulomatous colitis in boxer dogs

21 January 2018

1 reference

Remission of histiocytic ulcerative colitis in Boxer dogs correlates with eradication of invasive intramucosal Escherichia coli.

21 January 2018

1 reference

Antimicrobial resistance impacts clinical outcome of granulomatous colitis in boxer dogs

21 January 2018

1 reference

Development and validation of an endoscopic index of the severity for Crohn's disease: a prospective multicentre study. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires du Tube Digestif (GETAID)

21 January 2018

1 reference

RAPD (arbitrary primer) PCR is more sensitive than multilocus enzyme electrophoresis for distinguishing related bacterial strains

21 January 2018

1 reference

Rapid and simple determination of the Escherichia coli phylogenetic group

21 January 2018

1 reference

Rifaximin: a novel nonabsorbed rifamycin for gastrointestinal disorders

21 January 2018

1 reference

Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance

21 January 2018

1 reference

Development and validation of an oligonucleotide microarray for detection of multiple virulence and antimicrobial resistance genes in Escherichia coli

21 January 2018

1 reference

Replication of Colonic Crohn's Disease Mucosal Escherichia coli Isolates within Macrophages and Their Susceptibility to Antibiotics

21 January 2018

1 reference

Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics

21 January 2018

1 reference

The Role of Antibiotics in Inflammatory Bowel Disease

21 January 2018

1 reference

Antibiotic therapy in inflammatory bowel disease: a systematic review and meta-analysis.

21 January 2018

1 reference

Long‐Term Antibiotic Treatment for Crohn's Disease: Systematic Review and Meta‐Analysis of Placebo‐Controlled Trials

21 January 2018

1 reference

Crohn's disease in a southern European country: Montreal classification and clinical activity

21 January 2018

1 reference

Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer

21 January 2018

1 reference

A Nonsynonymous SNP in ATG16L1 Predisposes to Ileal Crohn’s Disease and Is Independent of CARD15 and IBD5

21 January 2018

1 reference

Adherent invasive Escherichia coli strains from patients with Crohn's disease survive and replicate within macrophages without inducing host cell death

21 January 2018

1 reference

Preliminary study of ciprofloxacin in active Crohn's disease

21 January 2018

1 reference

Clinical trial: randomized study of clarithromycin versus placebo in active Crohn's disease

21 January 2018

1 reference

Rifaximin for the treatment of newly diagnosed Crohn's disease: a case series

21 January 2018

1 reference

An open-label evaluation of rifaximin in the treatment of active Crohn's disease

21 January 2018

1 reference

Antibiotic treatment of Crohn's disease: results of a multicentre, double blind, randomized, placebo-controlled trial with rifaximin.

21 January 2018

1 reference

Development of Escherichia coli rifaximin-resistant mutants: frequency of selection and stability

21 January 2018

1 reference

NOD2/CARD15 gene variants are linked to failure of antibiotic treatment in perianal fistulating Crohn's disease

21 January 2018

1 reference

Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto- and microbial antigens

21 January 2018

1 reference

High-level serum antibodies to bacterial antigens are associated with antibiotic-induced clinical remission in Crohn's disease: a pilot study

21 January 2018

1 reference

Twin studies reveal specific imbalances in the mucosa-associated microbiota of patients with ileal Crohn's disease

21 January 2018

1 reference

Role of ATG16L1 Thr300Ala polymorphism in inflammatory bowel disease: a Study in the Spanish population and a meta-analysis

21 January 2018

1 reference

7 January 2021

Immunocytochemical evidence of Listeria, Escherichia coli, and Streptococcus antigens in Crohn's disease

1 reference

7 January 2021

Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum

1 reference

7 January 2021

Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease

1 reference

7 January 2021

Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD

1 reference

7 January 2021

Effect of topical 5-aminosalicylic acid (5-ASA) therapy on rectal mucosal biopsy morphology in chronic ulcerative colitis

1 reference

7 January 2021

Comparison of real-time PCR with SYBR Green I or 5'-nuclease assays and dot-blot hybridization with rDNA-targeted oligonucleotide probes in quantification of selected faecal bacteria

1 reference

7 January 2021

A controlled trial comparing ciprofloxacin with mesalazine for the treatment of active Crohn's disease. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID)

1 reference

7 January 2021

Sero-reactivity to microbial components in Crohn's disease is associated with disease severity and progression, but not NOD2/CARD15 genotype

1 reference

7 January 2021

Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice

1 reference

7 January 2021

Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology

1 reference

7 January 2021

Application of the Montreal classification for Crohn's disease to a single clinician database of 1015 patients

1 reference

7 January 2021